|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical study evaluating efficacy of praziquantel in clonorchiasis显示文摘 | Yangco BG De Lerma C Lyman GH | 1987 | Antimicrob Agents Chemother1987，31，2： | 1 |
| 2 | Lymphatic mapping and sentinel node biopsy in the patient with breast cancer 显示文摘 | Albertini J J Lyman GH Cox C | 1996 | JAMA1996，276，22： | 1 |
| 3 | Lymphatic mapping and sentinel node biopsy in the patient with breast cancer 显示文摘 | Albertini JJ Lyman GH Cox C | 1996 | JAJA1996，276，22： | 1 |
| 4 | Lymphatic mapping and sentinel node biopsy in the patient with breast cancer显示文摘 | Albertini JJ Lyman GH Cox C | 1996 | JAMA1996，276，22： | 1 |
| 5 | Effect of anteriorcruciate ligament reconstruction and meniscectomy on length of ca-reer in National Football League athletes : a case control study 显示文摘 | BROPHY R H GILL C S LYMAN S | 2009 | Am J Sports Med2009，37，1： | 1 |
| 6 | Supply chain management: A strategic perspective显示文摘 | Tan K C Lyman S B Wisner J D | 2002 | International Journal of Operations & Production Management2002，22，6： | 1 |
| 7 | Lymphatic mapping and sentinel node biopsy in the patient with breast cancer显示文摘 | Albertini J J Lyman GH Cox C | 1996 | JAMA1996，276，22： | 1 |
| 8 | High-sensitivity atomic magnetometer unaffected by spin-exchange relaxation显示文摘 | Allred J C Lyman R N Kornack T W | 2002 | Physical Review Letters2002，89，13： | 1 |
| 9 | Modeling laser-induced ignition of nitramine propellants with condensed and gas-phase absorption显示文摘 | Liau Y C Lyman J L | 2002 | Combustion Science and Technology2002，174，3： | 1 |
| 10 | Amniotic membrane for the prevention of postoperative peritoneal adhesions显示文摘 | Lyman C Bertgold WH | 1914 | Surg Gynecol Obstet1914，18，： | 1 |
| 11 | Speeding products to market: Waiting time to first product introduction in new firm 显示文摘 | Schoonhoven C B Eisenhardt K M Lyman K | 1990 | Administrative Science Quarterly1990，35，： | 1 |
| 12 | Speeding products to market:Waiting time to first product intro-duction in new firm 显示文摘 | Schoonhoven C B Eisenhardt K M Lyman K | 1990 | Ad- ministrative Science Quar-terly1990，，： | 1 |
| 13 | Lymphatic mapping and sentinel biopsy in the patients with breast cancer显示文摘 | Albeyrtini JJ Lyman GH Cox C | 1996 | JAMA1996，276，： | 1 |
| 14 | Lymphatic mapping and sentinel node biopsy in the patient with breast cancer显示文摘 | Albertini JJ Lyman GH Cox C | 1996 | JAMA1996，276，22： | 1 |
| 15 | 早期乳腺癌最佳辅助化疗方案与人类表皮生长因子受体2阳性乳腺癌辅助靶向治疗选择:依据 ASCO 对 CCO临床实践指南的改编显示文摘目的研究加拿大安大略癌症治疗中心(CCO)关于早期乳腺癌最佳辅助化疗方案,包括人类表皮生长因子受体2(HER2)阳性乳腺癌辅助靶向治疗方案,并对其进行改编。方法按照美国临床肿瘤协会(ASCO)对其他组织临床实践指南改编的策略和程序,对CCO临床实践指南的严谨性与内容适用性进行回顾。结果基于对CCO临床实践指南内容的回顾,ASCO小组认为,CCO临床实践指南在整体上清晰全面,以最确切的科学证据为基础,为患者提供可接受的治疗选项。推荐关于辅助化疗方案的决定,应考虑到基线复发风险、毒性、利益可能性和宿主因素(如合并症)。对于高风险HER2阴性的身体状况良好的人群,蒽环类和紫杉烷治疗方案是标准治疗方案。4个周期的多西他赛和环磷酰胺治疗方案是可接受的非蒽环类治疗方案。对于高风险HER2阳性患者,推荐蒽环类与紫杉烷序贯疗法联合曲妥单抗或多西他赛、卡铂、曲妥单抗进行6个周期的治疗。对于低风险、非淋巴结转移、HER2阳性人群,推荐每周一次的紫杉醇和曲妥单抗连续进行12个周期的替代治疗。曲妥单抗应持续使用1年。不应采用铂复合盐对三阴性人群进行常规的辅助管理,除非出现有效的生存数据加以支持。 | Neelima Denduluri Mark R Somerfield Andrea Eisen Jamie N Holloway Arti Hurria Tari A King Gary H Lyman Ann H Partridge Melinda L Telli Maureen E Trudeau Antonio C Wolff 本刊编辑部 | 2016 | 中国全科医学2016，19，18： | 1 |
| 16 | Lymphatic mapping and sentinel node biopsy in the patient with breast cancer显示文摘 | Albertini JJ lyman GH COX C | 1996 | JAMA1996，276，： | 1 |
| 17 | A phase Ⅲ randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck显示文摘 | Jacobs C Lyman G Velez-Garcia E | 1992 | J Clin Oncol1992，10，2： | 1 |
| 18 | High incidence of complications from enoxaparin treatment after arthroplasty显示文摘 | Neviaser AS Chang C Lyman S | 2010 | Clin Orthop Relat Res2010，468，1： | 1 |
| 19 | Plant-wide control of the Tennessee Eastman problem显示文摘 | Lyman C Georgakis P R | 1995 | Comput Chem Eng1995，19，3： | 1 |
| 20 | Lymphatic mapping and sentinel node biopsy in the patients with breast cancer显示文摘 | Albertini J J Lyman G H Cox C | 1996 | JAMA1996，276，22： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员